Aliases & Classifications for Chronic Tic Disorder

Aliases & Descriptions for Chronic Tic Disorder:

Name: Chronic Tic Disorder 12 14
Chronic Motor or Vocal Tic Disorder 12 69
Tic Disorders 42
Tic Disorder 69

Classifications:



External Ids:

Disease Ontology 12 DOID:10600
ICD10 33 F95.1 F95 F95.9
ICD9CM 35 307.22
MeSH 42 D013981
NCIt 47 C116768
SNOMED-CT 64 192623005
UMLS 69 C0008701

Summaries for Chronic Tic Disorder

Disease Ontology : 12 A tic disorder that is characterized by single or multiple motor or phonic tics, but not both, which are present for more than a year.

MalaCards based summary : Chronic Tic Disorder, also known as chronic motor or vocal tic disorder, is related to tic disorder and dahlberg borer newcomer syndrome, and has symptoms including symptoms and recurrent muscle twitches (symptom). An important gene associated with Chronic Tic Disorder is DRD4 (Dopamine Receptor D4), and among its related pathways/superpathways are Allograft rejection and Immune response Fc epsilon RI pathway. The drugs Methyltestosterone and Testosterone have been mentioned in the context of this disorder. Affiliated tissues include skin, b cells and brain, and related phenotype is homeostasis/metabolism.

Related Diseases for Chronic Tic Disorder

Diseases related to Chronic Tic Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 84)
id Related Disease Score Top Affiliating Genes
1 tic disorder 10.5
2 dahlberg borer newcomer syndrome 10.2 IL13 IL5
3 rectosigmoid junction neoplasm 10.2 DNAJC13 DRD4 HTR7
4 aortic atherosclerosis 10.2 IL13 IL5
5 renal hypertension 10.2 IL13 IL5
6 hypercementosis 10.2 IL13 IL5
7 choledochal cyst 10.1 CSF2 IL5
8 spastic diplegia 10.1 IL13 IL5
9 obsessive-compulsive disorder 10.1
10 disordered steroidogenesis due to cytochrome p450 oxidoreductase 10.1 IL13 IL5
11 crustacean allergy 10.1 IL13 IL4
12 necrotizing gastritis 10.1 CSF2 IL5
13 marasmus 10.1 IL4 IL5
14 smooth muscle tumor 10.1 IL13 IL5
15 goat milk allergy 10.1 IL13 IL4
16 papillary squamous carcinoma 10.1 IL4 IL5
17 lens-induced iridocyclitis 10.1 IL4 IL5
18 sarcoma 10.1 CSF2 IL4
19 prostate small cell carcinoma 10.1 IL13 IL5
20 hypersensitivity vasculitis 10.1 IL4 IL5
21 multiple epiphyseal dysplasia due to collagen 9 anomaly 10.1 IL4 IL5
22 urethral intrinsic sphincter deficiency 10.1 IL4 IL5
23 cerebral primitive neuroectodermal tumor 10.0 IL4 IL5
24 breast intracanalicular fibroadenoma 10.0 IL4 IL5
25 metal allergy 10.0 IL13 IL5
26 apricot allergy 10.0 IL4 IL5
27 exudative vitreoretinopathy 2, x-linked 10.0 CSF2 IL13 IL5
28 cutaneous fibrous histiocytoma 10.0 IL4 IL5
29 childhood malignant mesenchymoma 10.0 CSF2 IL13 IL5
30 allescheriosis 10.0 CTSB IL4 IL5
31 birth defects 10.0 CSF2 IL13 IL5
32 histoplasmosis retinitis 10.0 CTSB IL4 IL5
33 spastic paraplegia 3a, autosomal dominant 10.0 IL13 IL4 IL5
34 thelaziasis 10.0 IL13 IL4 IL5
35 lymphoblastic leukemia 10.0 IL13 IL4 IL5
36 bone peripheral neuroepithelioma 10.0 IL13 IL4 IL5
37 indian plum allergy 10.0 IL13 IL4 IL5
38 luminal breast carcinoma 10.0 IL13 IL4 IL5
39 acute gonococcal prostatitis 10.0 IL13 IL4 IL5
40 askin's tumor 10.0 IL13 IL4 IL5
41 trachea leiomyoma 10.0 IL13 IL4 IL5
42 visceral steatosis 10.0 IL13 IL4 IL5
43 isolated klippel-feil syndrome 10.0 IL4 IL5
44 lymphocytic gastritis 10.0 IL13 IL4 IL5
45 intravascular angioleiomyoma 10.0 IL13 IL4 IL5
46 duodenal somatostatinoma 10.0 IL13 IL4 IL5
47 inflamed seborrheic keratosis 10.0 IL13 IL4 IL5
48 hydrophthalmos 10.0 IL13 IL4 IL5
49 loiasis 10.0 IL13 IL4 IL5
50 eyelid neoplasm 10.0 IL13 IL4 IL5

Graphical network of the top 20 diseases related to Chronic Tic Disorder:



Diseases related to Chronic Tic Disorder

Symptoms & Phenotypes for Chronic Tic Disorder

UMLS symptoms related to Chronic Tic Disorder:


symptoms, recurrent muscle twitches (symptom)

MGI Mouse Phenotypes related to Chronic Tic Disorder:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.28 CSF2 CTSB DRD4 F12 HTR7 IL13

Drugs & Therapeutics for Chronic Tic Disorder

Drugs for Chronic Tic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 294)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methyltestosterone Approved Phase 4 58-18-4 6010
2
Testosterone Approved, Investigational Phase 4 58-22-0 6013
3
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 3 76631-46-4, 113775-47-6 68602 5311068 56032
4
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
5
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
6
Clonidine Approved Phase 4 4205-90-7 2803
7
Aripiprazole Approved, Investigational Phase 4,Phase 3 129722-12-9 60795
8
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
9
Ticagrelor Approved Phase 4,Phase 3 274693-27-5 9871419
10 Piracetam Approved Phase 4 7491-74-9
11
Guanfacine Approved, Investigational Phase 4,Phase 3 29110-47-2 3519
12
Riluzole Approved, Investigational Phase 4 1744-22-5 5070
13
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
14
Domperidone Approved, Investigational, Vet_approved Phase 4 57808-66-9 3151
15
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
16
Magnesium Sulfate Approved, Vet_approved Phase 4 7487-88-9 24083
17
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
18
Fluvoxamine Approved, Investigational Phase 4 54739-18-3 3404 5324346
19
Haloperidol Approved Phase 4 52-86-8 3559
20
Olanzapine Approved, Investigational Phase 4 132539-06-1 4585
21
Budesonide Approved Phase 4 51333-22-3 63006 5281004
22
Amlodipine Approved Phase 4 88150-42-9 2162
23
Codeine Approved, Illicit Phase 4 76-57-3 5284371
24
Guaifenesin Approved, Vet_approved Phase 4 93-14-1 3516
25
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
26
Cycloserine Approved Phase 4 68-41-7 401 6234
27
Benzocaine Approved Phase 4 1994-09-7, 94-09-7 2337
28
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3 437-38-7 3345
29
Midazolam Approved, Illicit Phase 4,Phase 3 59467-70-8 4192
30
Sufentanil Approved, Investigational Phase 4,Phase 3 56030-54-7 41693
31
Ticlopidine Approved Phase 4,Phase 3 55142-85-3 5472
32
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
33
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
34
Remifentanil Approved Phase 4 132875-61-7 60815
35
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
36
Galantamine Approved Phase 4 357-70-0 9651 908828, 9651
37 tannic acid Approved, Nutraceutical Phase 4
38
Clopidogrel Approved, Nutraceutical Phase 4,Phase 3 120202-66-6, 113665-84-2 60606
39 Anabolic Agents Phase 4
40 Androgens Phase 4
41 Antineoplastic Agents, Hormonal Phase 4
42 Hormone Antagonists Phase 4,Phase 3
43 Hormones Phase 4,Phase 3
44 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3
45 Pharmaceutical Solutions Phase 4,Phase 3
46 Testosterone 17 beta-cypionate Phase 4
47
Testosterone enanthate Phase 4 315-37-7 9416
48 Testosterone undecanoate Phase 4
49 Adrenergic Agents Phase 4,Phase 3,Phase 2
50 Adrenergic Agonists Phase 4,Phase 3

Interventional clinical trials:

(show top 50) (show all 259)
id Name Status NCT ID Phase
1 Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects Unknown status NCT01813201 Phase 4
2 Long Term Postoperative Cognitive Dysfunction in the Elderly Patients Unknown status NCT02301676 Phase 4
3 Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD Unknown status NCT00152750 Phase 4
4 Comparison of Keppra and Clonidine in the Treatment of Tics Completed NCT00370838 Phase 4
5 Guanfacine in Children With Tic Disorders Completed NCT01547000 Phase 4
6 Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder Completed NCT00241176 Phase 4
7 Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission Completed NCT01018056 Phase 4
8 Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections Completed NCT00001658 Phase 4
9 Surface Acoustic Wave Ultrasound in Trigeminal Neuralgia Pain Completed NCT01447108 Phase 4
10 Comparison 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in Patients With Moderate to Severe COPD Completed NCT02541006 Phase 4
11 The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity Completed NCT02958046 Phase 4
12 Controlled Hypotension During Functional Endoscopic Sinus Surgery Completed NCT01956981 Phase 4
13 Treatment of Obsessive-Compulsive Disorder Completed NCT00000373 Phase 4
14 Olanzapine in the Treatment of Hair Pulling (Trichotillomania) Completed NCT00182507 Phase 4
15 Impact of Dexmedetomidine on the Post-Operative Cognition Dysfunction(POCD) in Geriatric Patients Completed NCT02275182 Phase 4
16 Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD Completed NCT03028701 Phase 4
17 Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients Completed NCT03038451 Phase 4
18 Efficacy and Safety of Imuneks 10 mg Capsules in the Prophylaxis of Cold Completed NCT02807220 Phase 4
19 Evaluation of NaproxenSodium and CodeinePhosphate Combination in Osteoarthritis Completed NCT02501564 Phase 4
20 D-Cycloserine as an Adjunct to Internet-CBT for OCD Completed NCT01649895 Phase 4
21 Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM) Recruiting NCT02457130 Phase 4
22 Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment Recruiting NCT02988869 Phase 4
23 The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity Recruiting NCT02689999 Phase 4
24 The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy Recruiting NCT02939495 Phase 4
25 Impact of Anesthesia Maintenance Methods on Long-term Survival Rate Recruiting NCT02660411 Phase 4
26 Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity Active, not recruiting NCT01863459 Phase 4
27 Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets Not yet recruiting NCT03037606 Phase 4
28 The Safety of Dapoxetine/Tadalafil Combination Therapy Not yet recruiting NCT03177746 Phase 4
29 Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery Not yet recruiting NCT03172988 Phase 4
30 Safety Study of Galantamine in Tic Disorders Terminated NCT00226824 Phase 4
31 Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children Unknown status NCT00183391 Phase 3
32 Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children Completed NCT00218777 Phase 2, Phase 3
33 Phase III Study of 5LGr to Treat Tic Disorder Completed NCT01501695 Phase 3
34 Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder Completed NCT00706589 Phase 3
35 Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Completed NCT01727700 Phase 3
36 Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Completed NCT01727713 Phase 3
37 Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Completed NCT01418352 Phase 3
38 Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Completed NCT01418339 Phase 3
39 Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Completed NCT01416441 Phase 3
40 Preventive Sodium Lactate and Traumatic Brain Injury Completed NCT00995683 Phase 2, Phase 3
41 Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder Completed NCT00004376 Phase 3
42 An Open-Label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome. Completed NCT00206336 Phase 3
43 A Randomized, Placebo-Controlled, Tourette Syndrome Study. Completed NCT00206323 Phase 3
44 Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder Completed NCT00269815 Phase 3
45 A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural Therapy Completed NCT00564967 Phase 3
46 A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder Completed NCT00269802 Phase 3
47 Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication Completed NCT01131026 Phase 3
48 Efficacy and Safety Study of Udenafil Tablets in Erectile Dysfunction. Completed NCT01305083 Phase 3
49 Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery Completed NCT01837290 Phase 3
50 Pallidal Stimulation and Gilles de la Tourette Syndrome Completed NCT00478842 Phase 3

Search NIH Clinical Center for Chronic Tic Disorder

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: tic disorders

Genetic Tests for Chronic Tic Disorder

Anatomical Context for Chronic Tic Disorder

MalaCards organs/tissues related to Chronic Tic Disorder:

39
Skin, B Cells, Brain

Publications for Chronic Tic Disorder

Articles related to Chronic Tic Disorder:

(show all 32)
id Title Authors Year
1
The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review. ( 26880181 )
2016
2
Validity and reliability of chronic tic disorder and obsessive-compulsive disorder diagnoses in the Swedish National Patient Register. ( 26100027 )
2015
3
Electrophysiological similarities in Tourette syndrome and chronic tic disorder. ( 26531497 )
2015
4
Quality of life and self-esteem in children with chronic tic disorder. ( 26078684 )
2014
5
Association between pre- and perinatal exposures and Tourette syndrome or chronic tic disorder in the ALSPAC cohort. ( 24262815 )
2014
6
Tourette syndrome and chronic tic disorder are associated with lower socio-economic status: findings from the Avon Longitudinal Study of Parents and Children cohort. ( 24138188 )
2014
7
Mindfulness-based stress reduction for Tourette syndrome and chronic tic disorder: A pilot study. ( 25149879 )
2014
8
The role of obsessive-compulsive symptoms in the psychopathological profile of children with chronic tic disorder and attention-deficit hyperactivity disorder. ( 23639924 )
2013
9
Cognitive therapy of obsessive compulsive disorder with chronic tic disorder. ( 23833351 )
2013
10
Evidence-based assessment of compulsive skin picking, chronic tic disorders and trichotillomania in children. ( 22488574 )
2012
11
Exome sequencing of a pedigree with Tourette syndrome or chronic tic disorder. ( 21520241 )
2011
12
A proper name for chronic tic disorder. ( 20889671 )
2010
13
Cognitive behavioral management of Tourette's syndrome and chronic tic disorder in medicated and unmedicated samples. ( 19698938 )
2009
14
Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder. ( 19864199 )
2009
15
Obsessive-compulsive disorder in youth with and without a chronic tic disorder. ( 17345600 )
2008
16
Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder. ( 18439116 )
2008
17
Cognitive-behaviour therapy and skilled motor performance in adults with chronic tic disorder. ( 18058387 )
2008
18
Durability, negative impact, and neuropsychological predictors of tic suppression in children with chronic tic disorder. ( 17717739 )
2008
19
Quality of life in youth with Tourette's syndrome and chronic tic disorder. ( 17484694 )
2007
20
Psychopathological profile in children with chronic tic disorder and co-existing ADHD: additive effects. ( 17171537 )
2007
21
Memory and executive functions in adults with Gilles de la Tourette syndrome and chronic tic disorder. ( 17453897 )
2007
22
Association between the polymorphism in the promoter region of dopamine D4 receptor gene and chronic tic disorder. ( 17052389 )
2006
23
Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate. ( 16536367 )
2006
24
A computer-aided diagnosis for distinguishing Tourette's syndrome from chronic tic disorder in children by a fuzzy system with a two-step minimization approach. ( 15248548 )
2004
25
Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22. ( 15368493 )
2004
26
A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. ( 12090818 )
2002
27
Progress toward analysis of D8/17 binding to B cells in children with obsessive compulsive disorder and/or chronic tic disorder. ( 11694329 )
2001
28
Differences in 99mTc-HMPAO brain SPET perfusion imaging between Tourette's syndrome and chronic tic disorder in children. ( 11303888 )
2001
29
Associated psychopathology in children with both ADHD and chronic tic disorder. ( 8973069 )
1996
30
A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified. ( 8973076 )
1996
31
Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. ( 8038934 )
1994
32
The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. ( 8227493 )
1993

Variations for Chronic Tic Disorder

Expression for Chronic Tic Disorder

Search GEO for disease gene expression data for Chronic Tic Disorder.

Pathways for Chronic Tic Disorder

Pathways related to Chronic Tic Disorder according to GeneCards Suite gene sharing:

(show all 19)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.62 CTSB IL13 IL4 IL5
2
Show member pathways
12.38 CSF2 IL13 IL4 IL5
3
Show member pathways
12.13 CSF2 IL13 IL4 IL5
4
Show member pathways
11.95 IL13 IL4 IL5
5
Show member pathways
11.94 CSF2 IL13 IL4 IL5
6 11.8 CSF2 IL4 IL5
7 11.7 CSF2 IL4 IL5
8 11.6 IL13 IL4 IL5
9
Show member pathways
11.57 CSF2 IL4 IL5
10 11.47 CSF2 IL13 IL4 IL5
11 11.34 CSF2 IL13 IL4
12 11.3 IL13 IL4 IL5
13 11.1 IL4 IL5
14 11.06 CSF2 IL13 IL4 IL5
15 11.05 IL13 IL4 IL5
16 10.96 CSF2 IL13 IL4 IL5
17 10.91 IL13 IL4 IL5
18 10.51 IL13 IL4 IL5
19 10.4 CSF2 IL13 IL4 IL5

GO Terms for Chronic Tic Disorder

Cellular components related to Chronic Tic Disorder according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.1 CSF2 CTSB F12 IL13 IL4 IL5

Biological processes related to Chronic Tic Disorder according to GeneCards Suite gene sharing:

(show all 13)
id Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.8 CSF2 IL13 IL4 IL5
2 B cell activation GO:0042113 9.52 AKAP17A IL4
3 negative regulation of endothelial cell apoptotic process GO:2000352 9.51 IL13 IL4
4 myeloid dendritic cell differentiation GO:0043011 9.48 CSF2 IL4
5 positive regulation of tyrosine phosphorylation of Stat5 protein GO:0042523 9.46 CSF2 IL4
6 microglial cell activation GO:0001774 9.43 IL13 IL4
7 positive regulation of podosome assembly GO:0071803 9.4 CSF2 IL5
8 dendritic cell differentiation GO:0097028 9.37 CSF2 IL4
9 positive regulation of mast cell degranulation GO:0043306 9.32 IL13 IL4
10 positive regulation of immunoglobulin production GO:0002639 9.26 IL13 IL4
11 regulation of proton transport GO:0010155 9.16 IL13 IL4
12 negative regulation of complement-dependent cytotoxicity GO:1903660 8.96 IL13 IL4
13 positive regulation of B cell proliferation GO:0030890 8.8 IL13 IL4 IL5

Molecular functions related to Chronic Tic Disorder according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine receptor binding GO:0005126 9.16 IL13 IL4
2 growth factor activity GO:0008083 9.13 CSF2 IL4 IL5
3 cytokine activity GO:0005125 8.92 CSF2 IL13 IL4 IL5

Sources for Chronic Tic Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....